Anne Lesage sold $421K of Pharvaris (PHVS)

Executed Apr 22, disclosed Apr 24, 2 days later.

Value, as filed

$421K

14,000 sh across 2 lots

Executed

Apr 22

the trade date, as filed

Disclosed

Apr 24

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Anne Lesage Chief Early Development profile →

Anne Lesage (Chief Early Development) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Pharvaris N.V. (PHVS). The largest single filing was $2.6M of PHVS (73,872 sh across 4 lots, as filed), executed Jun 29.

The name

PHVS

Pharvaris N.V. PHVS · Healthcare · 30 filings in 24 months ticker →

Healthcare · Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases wit…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Anne Lesage in PHVS

PHVSSALE Pharvaris N.V. $765K
20,000 sh × $38.27
Exec Sep 17
Filed Sep 21 · 3:13 PM ET PHVSSALE Pharvaris N.V. $1.1M
30,000 sh × $38.30
Exec Sep 10
Filed Sep 14 · 12:29 PM ET PHVSSALE Pharvaris N.V. $2.6M
73,872 sh across 4 lots
Exec Jun 29
Filed Jul 1 · 7:02 PM ET PHVSSALE Pharvaris N.V. $1.5M
48,300 sh across 5 lots
Exec Apr 29
Filed May 1 · 5:30 PM ET